Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

During the Trading Day
120.93 +5.11 / +4.41%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
120.93 0.00 / 0.00%
 
Volume: 115.2K
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close115.82
Today’s open115.09
Day’s range115.09 - 121.38
Volume709,171
Average volume (3 months)553,034
Market cap$4.6B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+84.87%
Earnings growth (this year)-17.28%
Earnings growth (next 5 years)+75.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book20.82

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+0.10+0.20%
ACADACADIA Pharmaceutica...+0.99+2.07%
GRFSGrifols SA-0.45-1.37%
AKRXAkorn Inc-0.22-0.47%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$0.00
Annual profit (last year)-$59.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, Senior VP &
Head-Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts